Intraperitoneal anti-PD-L1 increases survival in a novel ovarian cancer model and its in vivo efficacy is influenced by baseline anti-tumor immunity of the host

被引：0
|
作者：
Mony, Jyothi
Zhang, Lixin
Tirodkar, Tejas
Elishaev, Esther
Brozick, Joan
Edwards, Robert P.
Vlad, Anda M.
机构：
[1] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA
[2] Magee Womens Res Inst, Pittsburgh, PA USA
来源：
CLINICAL CANCER RESEARCH | 2015年 / 21卷
关键词：
D O I：
10.1158/1557-3265.OVCASYMP14-POSTER-THER-1434
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
THER-1434
引用
收藏
页数：2
相关论文
共 50 条
  • [21] ANTI-PD-L1/IL-15 KD033 ACTIVATED MACROPHAGES AND INDUCED ANTI-TUMOR IMMUNITY IN THE TUMOR-MICROENVIRONMENT
    Martomo, Stella
    Wang, George
    Polonskaya, Zhanna
    Luna, Xenia
    Lu, Dan
    Patel, Jeegar
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A681 - A681
  • [22] Combination of ANTI-PD-1/ANTI-PD-L1 Antibodies With the Distinct Character Exerts Preferable Anti-Tumor Immune Cycle in a Murine Neuroblastoma Model
    Inoue, S.
    Horiuchi, Y.
    Setoyama, Y.
    Takeuchi, Y.
    Murakami, T.
    Odaka, A.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S157 - S157
  • [23] Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
    Sivan, Ayelet
    Corrales, Leticia
    Hubert, Nathaniel
    Williams, Jason B.
    Aquino-Michaels, Keston
    Earley, Zachary M.
    Benyamin, Franco W.
    Lei, Yuk Man
    Jabri, Bana
    Alegre, Maria-Luisa
    Chang, Eugene B.
    Gajewski, Thomas F.
    SCIENCE, 2015, 350 (6264) : 1084 - 1089
  • [24] A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention
    Chen, Jie
    Liu, Hui
    Jehng, Tiffany
    Li, Yanqing
    Chen, Zhoushi
    Lee, Kuan-Der
    Shen, Hsieh-Tsung
    Jones, Lindsey
    Huang, Xue F.
    Chen, Si-Yi
    CANCERS, 2019, 11 (12)
  • [25] Anti-tumor immunity and efficacy of combination treatment of M6223 and bintrafusp alfa versus the combination of M6223 and anti-PD-L1 in preclinical tumor models
    Xu, Chunxiao
    Yalavarthi, Sireesha
    Bourin, Clotilde
    Kelton, Christie
    Halle, Joern-Peter
    Moisan, Jacques
    CANCER RESEARCH, 2022, 82 (12)
  • [26] M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine
    Knudson, Karin M.
    Hicks, Kristin C.
    Luo, Xiaoling
    Chen, Jin-Qiu
    Schlom, Jeffrey
    Gameiro, Sofia R.
    ONCOIMMUNOLOGY, 2018, 7 (05):
  • [27] Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma
    Ray, A.
    Das, D. S.
    Song, Y.
    Hideshima, T.
    Tai, Y-T
    Chauhan, D.
    Anderson, K. C.
    LEUKEMIA, 2018, 32 (03) : 843 - 846
  • [28] Analysis of Anti-Tumor Immune Responses with Radiation Combined with Anti-PD-L1 Immunotherapy in an HPV Specific Head & Neck Cancer Model.
    Guram, K.
    Sanders, P. D.
    Miyauchi, S.
    Kim, S.
    Venuti, A.
    Cohen, E.
    Gutkind, J. S.
    Mell, L. K.
    Sharabi, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S153 - S153
  • [29] Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma
    A Ray
    D S Das
    Y Song
    T Hideshima
    Y-T Tai
    D Chauhan
    K C Anderson
    Leukemia, 2018, 32 : 843 - 846
  • [30] Anti-tumor and immune effects of olaparib plus /- anti-PD-L1 in preclinical BRCA1mut tumor models
    Staniszewska, Anna
    Armenia, Joshua
    King, Matthew
    Michaloglou, Chrysiis
    Singh, Maneesh
    San Martin, Maryann
    Wilson, Zena
    Proia, Theresa
    Delpuech, Oona
    O'Connor, Mark
    Leo, Elisabetta
    Valge-Archer, Viia
    CANCER RESEARCH, 2020, 80 (16)
12345